The European Bank for Reconstruction and Development (EBRD) has provided JSC Farmak (Kyiv) with a loan of EUR 20 million to replenish working capital, according to a press release from the EBRD.
"The EBRD is lending EUR 20 million to a leading Ukrainian pharmaceuticals manufacturer, JSC Farmak, under its EUR 2 billion Resilience and Livelihoods Framework supporting countries affected by the war in Ukraine," the report says.
The program provides for the sustainability and preservation of livelihoods and support for countries affected by the war in Ukraine.
According to the EBRD, the total amount of the Program is EUR 2 billion.
The EBRD reports that this loan has a 5.5% first loss guarantee under the EBRD's Shareholder Special Fund Risk Sharing Programme. Thus, the total donor guarantee will cover 50% of the loan amount.
Advertising
Advertising
MORE ABOUT
EBRD will consider co-investing with UDF in future
12:15, 26.03.2024
EBRD provides $25 mln trade finance limit to PrivatBank
12:50, 14.03.2024
EBRD to provide EUR 200 mln loan to Ukrhydroenergo for emergency restoration of HPPs
15:02, 29.01.2024
OTP Bank offers investment loans to SME clients with possibility of reimbursement of up to 20% of funds received
17:12, 27.12.2023
Ukraine agrees to raise EUR 150 mln from EBRD to support Ukrenergo
16:07, 15.12.2023
LATEST
New EU sanctions will apply to supplies of manganese ore and aluminum oxide to Russia – Latvian authorities
21:07, 03.05.2024
NBU lifts restrictions on import of works, services; introduces other currency concessions
21:01, 03.05.2024
Ukrainian coal could be exported due to shutdown of Centerenergo in Russian heavy shelling – Minister of Energy
19:26, 03.05.2024
NBU requires Getin Holding to sell Idea Bank within six months
10:09, 03.05.2024
DIM company accredits houses under construction in eOselia program